Rising Rheumatoid Arthritis Cases Driving The Market Growth: An Emerging Driver Transforming The Arthralgia Market Landscape

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Projected Growth of the Arthralgia Market?
In recent times, the arthralgia market has seen substantial growth. It is projected to rise from $5.20 billion in 2024 to $5.64 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period is largely due to several factors such as the rising number of autoimmune diseases, the emergence of numerous risk factors associated with it, a surge in obesity cases, growing instances of arthralgia, and an uptick in the prevalence of joint disorders.

Anticipated to witness a robust expansion in the upcoming years, the arthralgia market is predicted to escalate to a valuation of $7.73 billion by 2029, with a compound annual growth rate (CAGR) of 8.2%. The projected growth during this period can be credited to the increasing cognizance of arthralgia, a growing elderly demographic, advancing healare facilities, a surge in demand for minor invasive procedures, and an increase in the occurrence of sport-related injuries. The prediction period will see key trends such as incorporation of digital healare solutions, innovation in therapies, cellular treatments, advancements in the sector of medical technology, and funding in research and development.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21104

What Are the Different Arthralgia Market Segments?
The arthralgia market covered in this report is segmented -

1) By Cause: Osteoarthritis, Rheumatoid Arthritis, Gout, Psoriatic Arthritis, Lupus, Injuries, Infections, Other Causes
2) By Treatment Type: Medications, Therapies, Surgical Interventions, Lifestyle And Home Remedies
3) By Route Of Administration: Oral, Injectable, Topical, Transdermal
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospital, Clinics, Homecare Settings, Rehabilitation Centers

Subsegments:
1) By Osteoarthritis: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Spine Osteoarthritis, Shoulder Osteoarthritis
2) By Rheumatoid Arthritis: Seropositive Rheumatoid Arthritis, Seronegative Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Early-Onset Rheumatoid Arthritis
3) By Gout: Primary Gout, Secondary Gout, Gouty Arthritis
4) By Psoriatic Arthritis: Symmetric Psoriatic Arthritis, Asymmetric Psoriatic Arthritis, Psoriatic Spondylitis, Distal Interphalangeal Predominant Psoriatic Arthritis
5) By Lupus: Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus, Drug-induced Lupus, Neonatal Lupus
6) By Injuries: Sports-related Injuries, Trauma and Fractures, Sprains and Strains, Tendon or Ligament Damage
7) By Infections: Septic Arthritis, Viral Arthritis, Bacterial Infections, Fungal Infections
8) By Other Causes: Fibromyalgia, Overuse Injuries, Sarcoidosis, Ankylosing Spondylitis, Crystal-induced Arthritis

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21104&type=smp

What Are the Primary Drivers Shaping the Arthralgia Market?
The growth of the arthralgia market is anticipated to be propelled by the escalating incidence of rheumatoid arthritis. This chronic autoimmune disease largely affects the joints, leading to inflammation, pain, and possibly causing damage to the joint. The surge in incidence of rheumatoid arthritis is linked to factors such as aging population, genetic factors, changes in lifestyle, and exposure to environmental factors like pollution and smoking. By way of example, in February 2024, Arthritis Australia, a not-for-profit organization in Australia, predicted that by 2040, arthritis cases in the country will grow from 4.11 million in 2025 to 5.39 million, with the count of osteoarthritis cases increasing to 3.11 million from 2.35 million, and cases of rheumatoid arthritis expected to touch 748,721. The arthralgia market is thus being driven by the mounting cases of rheumatoid arthritis.

Which Companies Are Leading in the Arthralgia Market?
Major companies operating in the arthralgia market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., UCB S.A., Hikma Pharmaceuticals PLC, Ferring Pharmaceuticals, KD Pharma Group S.A., SI-BONE Inc., Xalud Therapeutics Inc., Incannex Healare Limited, Cytonics Corporation, Vitazan Herbs and Vitamins Inc.

What Trends Are Driving Growth in The Arthralgia Market?
Leading businesses in the arthralgia market are concentrating their efforts on creating new and innovative therapies such as RMAT-designated gene therapy. This treatment strategy, which has been awarded the Regenerative Medicine Advanced Therapy (RMAT) designation by the FDA, is rapidly advancing the development and approval of novel therapeutic methods for critical or fatal conditions. For example, in March 2024, Pacira BioSciences Inc., a pharmaceutical firm from the US, acquired the RMAT designation for their product, PCRX-201 (enekinragene inzadenovec) from the FDA. This groundbreaking intra-articular gene therapy utilizes a helper-dependent adenovirus (HDAd) in the treatment of knee osteoarthritis and is engineered to generate interleukin-1 receptor antagonists (IL-1Ra). Pacira was honored by the FDA's premiere RMAT designation for a gene therapy aimed at osteoarthritis and highlighted the encouraging initial clinical results which hint that PCRX-201 could eventually modify the course of the disease.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/arthralgia-global-market-report

What Are the Top Revenue-Generating Geographies in the Arthralgia Market?
North America was the largest region in the arthralgia market in 2024. The regions covered in the arthralgia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Arthralgia Market?
2. What is the CAGR expected in the Arthralgia Market?
3. What Are the Key Innovations Transforming the Arthralgia Industry?
4. Which Region Is Leading the Arthralgia Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.